Differences in cancer prevalence among

myasthenickids

Differences in cancer prevalence among CHEK2 carriers identified via multi-gene panel testing

Purpose: Although CHEK2 is a well-established cancer gene, questions remain including whether risks vary substantially between different variants and whether biallelic carriers have higher risks than heterozygotes. We report on a cohort of individuals with CHEK2 pathogenic and likely pathogenic variants (collectively, PV) in order to better characterize this gene.
Methods: We retrospectively queried samples submitted for multi-gene hereditary cancer testing to identify individuals with CHEK2 PVs and assessed differences in phenotypes among various genotypes.
Results: CHEK2 PVs were identified in 2508 individuals, including 32 individuals with biallelic CHEK2 PVs. Breast (female, 59.9% and male, 11.8%), prostate (20.1%), and colorectal (3.5%), were among the most frequently reported cancers. Select missense PVs showed similar cancer prevalence to truncating PVs while some others showed lower prevalence. No significant differences were observed between biallelic carriers and heterozygotes.
Conclusions: Our data support that some, but not all, CHEK2 missense PVs demonstrate lower cancer prevalence; further studies are needed to continue characterizing possible variant specific risks. In addition, biallelic CHEK2 PVs do not appear to be associated with a more severe phenotype than single CHEK2 PVs. Furthermore, co-occurrences with PVs in other cancer risk genes are common among CHEK2 heterozygotes and often warrant additional management.
myasthenickids
myasthenickids

PSMB8 Antibody
1-CSB-PA116429
  • Ask for price
  • Ask for price
  • 50ul
  • 100ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100

PSMB8 Antibody
1-CSB-PA775839
  • Ask for price
  • Ask for price
  • 50ul
  • 100ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100

PSMB8 Antibody
E043134 100μg/100μl
EUR 255
Description: Available in various conjugation types.

PSMB8 Antibody
BF0434 200ul
EUR 540

PSMB8 Antibody
BF0434-100ul 100ul
EUR 210
Description: WB,IHC,IF/ICC,ELISA

PSMB8 Antibody
BF0434-200ul 200ul Ask for price
Description: WB,IHC,IF/ICC,ELISA

PSMB8 Antibody
BF0434-50ul 50ul
EUR 150
Description: WB,IHC,IF/ICC,ELISA

PSMB8 Antibody
E94054 100μg
EUR 255
Description: Available in various conjugation types.

PSMB8 Antibody
E314816 100ug/200ul
EUR 295
Description: Available in various conjugation types.

PSMB8 Antibody
E97340 100ul
EUR 255
Description: Available in various conjugation types.

PSMB8 Antibody
MBS5312424-01mL 0.1mL
EUR 1070

PSMB8 Antibody
MBS5312424-5x01mL 5x0.1mL
EUR 4655

PSMB8 Antibody
MBS7113266-005mL 0.05mL
EUR 190

PSMB8 Antibody
MBS7113266-01mL 0.1mL
EUR 270

PSMB8 Antibody
MBS7113266-5x01mL 5x0.1mL
EUR 1205

PSMB8 Antibody
MBS7129229-005mL 0.05mL
EUR 190

PSMB8 Antibody
MBS7129229-01mL 0.1mL
EUR 270

PSMB8 Antibody
MBS7129229-5x01mL 5x0.1mL
EUR 1205

PSMB8 Antibody
MBS7129230-005mL 0.05mL
EUR 190

PSMB8 Antibody
MBS7129230-01mL 0.1mL
EUR 270

PSMB8 Antibody
MBS7129230-5x01mL 5x0.1mL
EUR 1205

PSMB8 Antibody
MBS8500013-01mg 0.1mg
EUR 325

PSMB8 Antibody
MBS8500013-01mLAF405L 0.1mL(AF405L)
EUR 565

PSMB8 Antibody
MBS8500013-01mLAF405S 0.1mL(AF405S)
EUR 565

PSMB8 Antibody
MBS8500013-01mLAF610 0.1mL(AF610)
EUR 565

PSMB8 Antibody
MBS8500013-01mLAF635 0.1mL(AF635)
EUR 565

PSMB8 antibody
MBS9405580-01mL 0.1mL
EUR 420

PSMB8 antibody
MBS9405580-5x01mL 5x0.1mL
EUR 1740

PSMB8 Antibody
MBS9416351-01mL 0.1mL
EUR 305

PSMB8 Antibody
MBS9416351-5x01mL 5x0.1mL
EUR 1230

PSMB8 Polyclonal Antibody
A73468
  • Ask for price
  • Ask for price
  • 50 ul
  • 100 ul

PSMB8 Conjugated Antibody
C43134 100ul
EUR 476.4

PSMB8 polyclonal antibody
BS91127 50ul
EUR 398
Description: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

PSMB8 polyclonal antibody
BS78214 50ul
EUR 358
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

PSMB8 polyclonal antibody
BS8845 50 ul
EUR 358
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

PSMB8 Polyclonal Antibody
E-AB-92394-120uL 120uL
EUR 320
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-92394-200uL 200uL
EUR 530
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-92394-60uL 60uL
EUR 200
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-92394-each each Ask for price
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-61655-120uL 120uL
EUR 320
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-61655-200uL 200uL
EUR 530
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-61655-60uL 60uL
EUR 200
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-61655-each each Ask for price
Description: Unconjugated

PSMB8 monoclonal antibody
MB66639 50ul
EUR 275
Description: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide, pH 7.3.

PSMB8 Polyclonal Antibody
MBS2538339-006mL 0.06mL
EUR 190

PSMB8 Polyclonal Antibody
MBS2538339-012mL 0.12mL
EUR 265

PSMB8 Polyclonal Antibody
MBS2538339-02mL 0.2mL
EUR 415

PSMB8 Polyclonal Antibody
MBS2538339-5x02mL 5x0.2mL
EUR 1835

PSMB8 Polyclonal Antibody
MBS2528965-002mL 0.02mL
EUR 140

PSMB8 Polyclonal Antibody
MBS2528965-006mL 0.06mL
EUR 180

PSMB8 Polyclonal Antibody
MBS2528965-012mL 0.12mL
EUR 260

PSMB8 Polyclonal Antibody
MBS2528965-02mL 0.2mL
EUR 405

PSMB8 Polyclonal Antibody
MBS2528965-5x02mL 5x0.2mL
EUR 1725

PSMB8 Polyclonal Antibody
MBS2527805-002mL 0.02mL
EUR 140

PSMB8 Polyclonal Antibody
MBS2527805-006mL 0.06mL
EUR 180

PSMB8 Polyclonal Antibody
MBS2527805-012mL 0.12mL
EUR 260

PSMB8 Polyclonal Antibody
MBS2527805-02mL 0.2mL
EUR 405

PSMB8 Polyclonal Antibody
MBS2527805-5x02mL 5x0.2mL
EUR 1725

PSMB8 Conjugated Antibody
MBS9451453-01mLAF350 0.1mL(AF350)
EUR 480

PSMB8 Conjugated Antibody
MBS9451453-01mLAF405 0.1mL(AF405)
EUR 480

PSMB8 Conjugated Antibody
MBS9451453-01mLAF488 0.1mL(AF488)
EUR 480

PSMB8 Conjugated Antibody
MBS9451453-01mLAF555 0.1mL(AF555)
EUR 480

PSMB8 Conjugated Antibody
MBS9451453-01mLBiotin 0.1mL(Biotin)
EUR 480

PSMB8 Polyclonal Antibody
RD84433A-120uL 120μL
EUR 360
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit.

PSMB8 Polyclonal Antibody
RD84433A-200uL 200μL
EUR 630
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit.

PSMB8 Polyclonal Antibody
RD84433A-60uL 60μL
EUR 204
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit.

PSMB8 Antibody (N-term)
MBS9213569-008mL 0.08mL
EUR 210

PSMB8 Antibody (N-term)
MBS9213569-04mL 0.4mL
EUR 430

PSMB8 Antibody (N-term)
MBS9213569-5x04mL 5x0.4mL
EUR 1910

PSMB8 Antibody, HRP conjugated
1-CSB-PA018886LB01HU
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

PSMB8 Antibody, HRP Conjugated
MBS7113267-005mL 0.05mL
EUR 190

PSMB8 Antibody, HRP Conjugated
MBS7113267-01mL 0.1mL
EUR 270

PSMB8 Antibody, HRP Conjugated
MBS7113267-5x01mL 5x0.1mL
EUR 1205

PSMB8 Antibody, FITC conjugated
1-CSB-PA018886LC01HU
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

PSMB8 Antibody, FITC Conjugated
MBS7113268-005mL 0.05mL
EUR 190

PSMB8 Antibody, FITC Conjugated
MBS7113268-01mL 0.1mL
EUR 270

PSMB8 Antibody, FITC Conjugated
MBS7113268-5x01mL 5x0.1mL
EUR 1205

OACD05288-1ML - PSMB8 Antibody
OACD05288-1ML 1ml
EUR 649

OACD05289-1ML - PSMB8 Antibody
OACD05289-1ML 1ml
EUR 659

OACD05290-1ML - PSMB8 Antibody
OACD05290-1ML 1ml
EUR 639

OAAN02231-50UL - PSMB8 Antibody
OAAN02231-50UL 50ul
EUR 149

PSMB8 Antibody, Biotin conjugated
1-CSB-PA018886LD01HU
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

PSMB8 Antibody, Biotin Conjugated
MBS7113269-005mL 0.05mL
EUR 190

PSMB8 Antibody, Biotin Conjugated
MBS7113269-01mL 0.1mL
EUR 270

PSMB8 Antibody, Biotin Conjugated
MBS7113269-5x01mL 5x0.1mL
EUR 1205

Integration of genetic counsellors in genomic testing triage: Outcomes of a Genomic Consultation Service in British Columbia, Canada

Purpose: Clinical diagnostic genome-wide (exome or genome) sequencing (GWS) in British Columbia requires funding approval by a provincial agency on a case-by-case basis. The CAUSES Clinic was a pediatric translational trio-based GWS study at BC Children’s and Women’s Hospitals.
Referrals to the CAUSES Clinic were made through a Genomic Consultation Service (GCS), a multidisciplinary team led by genetic counsellors that provided advice regarding genomic testing for physicians considering GWS for their patients.
Here we review the outcomes of the GCS, focusing on patients not recommended for the CAUSES Study.
Methods: Demographic, clinical, and testing data were abstracted from patient charts. Logistic regression analysis was used to explore associations between demographic and clinical variables and two outcomes: the type of recommendation and referring physicians’ decisions to follow the recommendation.
Results: Of 972 GCS referrals, 248 patients were not referred to the CAUSES Study. GWS (vs. a targeted test; e.g. multi-gene panel) was more likely to be recommended to physicians of patients with ID than physicians of patients without ID (OR = 2.98; 95% CI = 1.46 to 6.27; n = 149). In total, 40% of physicians who were recommended to pursue clinical genomic testing submitted an application for funding approval; 71% of applications were approved for funding. Among approved tests, 50% resulted in a diagnosis, including 33% of targeted tests and 82% of GWS tests (χ2 (1) = 5.0, p = 0.026).
Conclusion: The GCS provided an effective model in which physicians can interface with genetic specialists, including genetic counsellors, to facilitate appropriate genomic test selection.

From Probands to Relatives: Communication of Genetic Risk for Hereditary Breast-Ovarian Cancer and Its Influence on Subsequent Testing

Background: The genetic risk communication from proband to relatives varies from family to family, and patients often need support with the communication of genetic test results and making decisions to manage hereditary cancer risks.
Objective: The aim of this study was to characterize the communication of BRCA1 or BRCA2 (BRCA1/2) genetic risk from proband to first-degree relatives (FDRs) using a social network framework.
Methods: We characterized network and nonnetwork factors to explore their association with which FDRs were told about the genetic risk and whether or not relatives underwent genetic testing. Ninety-two female probands with hereditary breast and ovarian cancer who have confirmed BRCA1/2 mutations participated in the study. Communication of hereditary breast and ovarian cancer risk was assessed between 92 probands and their 417 FDRs.
Results: Of 92 probands, 94.5% (n = 87) communicated their genetic test result to at least one of their FDRs. Of FDRs older than 18 years, 19.9% (n = 72) have genetic testing. Emotional closeness, educational level of the proband, and relative’s age were significantly associated with communicating test results with FDRs.
Conclusion: Communication of genetic risk with the FDRs after having a BRCA1/2 gene-mutation-positive test result was high in this group of cancer patients. However, the rate of genetic testing among FDRs was low.
Implications for practice: Probands’ educational level and age of relatives for cascade genetic screening should be considered during counseling. Interventions to support women with BRCA1/2 mutations during the communication process and their family members’ engagement in testing and risk-reducing strategies are needed.

PSMB8 Antibody
1-CSB-PA775839
  • Ask for price
  • Ask for price
  • 50ul
  • 100ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100

PSMB8 Antibody
1-CSB-PA116429
  • Ask for price
  • Ask for price
  • 50ul
  • 100ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100

PSMB8 Antibody
1-CSB-PA018886GA01HU
  • Ask for price
  • Ask for price
  • 50ul
  • 150ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF

PSMB8 Antibody
1-CSB-PA018886LA01HU
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

PSMB8 Antibody
E043134 100μg/100μl
EUR 255
Description: Available in various conjugation types.

PSMB8 Antibody
E314816 100ug/200ul
EUR 295
Description: Available in various conjugation types.

PSMB8 Antibody
E97340 100ul
EUR 255
Description: Available in various conjugation types.

PSMB8 Antibody
E94054 100μg
EUR 255
Description: Available in various conjugation types.

PSMB8 Antibody
MBS5312424-01mL 0.1mL
EUR 1070

PSMB8 Antibody
MBS5312424-5x01mL 5x0.1mL
EUR 4655

PSMB8 Antibody
MBS7129229-005mL 0.05mL
EUR 190

PSMB8 Antibody
MBS7129229-01mL 0.1mL
EUR 270

PSMB8 Antibody
MBS7129229-5x01mL 5x0.1mL
EUR 1205

PSMB8 Antibody
MBS7129230-005mL 0.05mL
EUR 190

PSMB8 Antibody
MBS7129230-01mL 0.1mL
EUR 270

PSMB8 Antibody
MBS7129230-5x01mL 5x0.1mL
EUR 1205

PSMB8 Antibody
MBS7113266-005mL 0.05mL
EUR 190

PSMB8 Antibody
MBS7113266-01mL 0.1mL
EUR 270

PSMB8 Antibody
MBS7113266-5x01mL 5x0.1mL
EUR 1205

PSMB8 antibody
MBS9405580-01mL 0.1mL
EUR 420

PSMB8 antibody
MBS9405580-5x01mL 5x0.1mL
EUR 1740

PSMB8 Antibody
MBS9416351-01mL 0.1mL
EUR 305

PSMB8 Antibody
MBS9416351-5x01mL 5x0.1mL
EUR 1230

PSMB8 Antibody
MBS8500013-01mg 0.1mg
EUR 325

PSMB8 Antibody
MBS8500013-01mLAF405L 0.1mL(AF405L)
EUR 565

PSMB8 Antibody
MBS8500013-01mLAF405S 0.1mL(AF405S)
EUR 565

PSMB8 Antibody
MBS8500013-01mLAF610 0.1mL(AF610)
EUR 565

PSMB8 Antibody
MBS8500013-01mLAF635 0.1mL(AF635)
EUR 565

PSMB8 Polyclonal Antibody
A73468
  • Ask for price
  • Ask for price
  • 50 ul
  • 100 ul

PSMB8 polyclonal antibody
BS8845 50 ul
EUR 358
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

PSMB8 polyclonal antibody
BS91127 50ul
EUR 398
Description: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

PSMB8 Polyclonal Antibody
E-AB-92394-120uL 120uL
EUR 320
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-92394-200uL 200uL
EUR 530
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-92394-60uL 60uL
EUR 200
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-92394-each each Ask for price
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-61655-120uL 120uL
EUR 320
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-61655-200uL 200uL
EUR 530
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-61655-60uL 60uL
EUR 200
Description: Unconjugated

PSMB8 Polyclonal Antibody
E-AB-61655-each each Ask for price
Description: Unconjugated

PSMB8 Conjugated Antibody
C43134 100ul
EUR 476.4

PSMB8 polyclonal antibody
BS78214 50ul
EUR 358
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

PSMB8 monoclonal antibody
MB66639 50ul
EUR 275
Description: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide, pH 7.3.

PSMB8 Polyclonal Antibody
MBS2538339-006mL 0.06mL
EUR 190

PSMB8 Polyclonal Antibody
MBS2538339-012mL 0.12mL
EUR 265

PSMB8 Polyclonal Antibody
MBS2538339-02mL 0.2mL
EUR 415

PSMB8 Polyclonal Antibody
MBS2538339-5x02mL 5x0.2mL
EUR 1835

PSMB8 Polyclonal Antibody
MBS2527805-002mL 0.02mL
EUR 140

PSMB8 Polyclonal Antibody
MBS2527805-006mL 0.06mL
EUR 180

PSMB8 Polyclonal Antibody
MBS2527805-012mL 0.12mL
EUR 260

PSMB8 Polyclonal Antibody
MBS2527805-02mL 0.2mL
EUR 405

PSMB8 Polyclonal Antibody
MBS2527805-5x02mL 5x0.2mL
EUR 1725

PSMB8 Polyclonal Antibody
MBS2528965-002mL 0.02mL
EUR 140

PSMB8 Polyclonal Antibody
MBS2528965-006mL 0.06mL
EUR 180

PSMB8 Polyclonal Antibody
MBS2528965-012mL 0.12mL
EUR 260

PSMB8 Polyclonal Antibody
MBS2528965-02mL 0.2mL
EUR 405

PSMB8 Polyclonal Antibody
MBS2528965-5x02mL 5x0.2mL
EUR 1725

PSMB8 Conjugated Antibody
MBS9451453-01mLAF350 0.1mL(AF350)
EUR 480

PSMB8 Conjugated Antibody
MBS9451453-01mLAF405 0.1mL(AF405)
EUR 480

PSMB8 Conjugated Antibody
MBS9451453-01mLAF488 0.1mL(AF488)
EUR 480

PSMB8 Conjugated Antibody
MBS9451453-01mLAF555 0.1mL(AF555)
EUR 480

PSMB8 Conjugated Antibody
MBS9451453-01mLBiotin 0.1mL(Biotin)
EUR 480

PSMB8 Polyclonal Antibody
RD84433A-120uL 120μL
EUR 360
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit.

PSMB8 Polyclonal Antibody
RD84433A-200uL 200μL
EUR 630
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit.

PSMB8 Polyclonal Antibody
RD84433A-60uL 60μL
EUR 204
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit.

PSMB8 Antibody (N-term)
MBS9213569-008mL 0.08mL
EUR 210

PSMB8 Antibody (N-term)
MBS9213569-04mL 0.4mL
EUR 430

PSMB8 Antibody (N-term)
MBS9213569-5x04mL 5x0.4mL
EUR 1910

PSMB8 Antibody, HRP conjugated
1-CSB-PA018886LB01HU
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

PSMB8 Antibody, HRP Conjugated
MBS7113267-005mL 0.05mL
EUR 190

PSMB8 Antibody, HRP Conjugated
MBS7113267-01mL 0.1mL
EUR 270

PSMB8 Antibody, HRP Conjugated
MBS7113267-5x01mL 5x0.1mL
EUR 1205

PSMB8 Antibody, FITC conjugated
1-CSB-PA018886LC01HU
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

PSMB8 Antibody, FITC Conjugated
MBS7113268-005mL 0.05mL
EUR 190

PSMB8 Antibody, FITC Conjugated
MBS7113268-01mL 0.1mL
EUR 270

PSMB8 Antibody, FITC Conjugated
MBS7113268-5x01mL 5x0.1mL
EUR 1205

OACD05288-1ML - PSMB8 Antibody
OACD05288-1ML 1ml
EUR 649

OACD05289-1ML - PSMB8 Antibody
OACD05289-1ML 1ml
EUR 659

OACD05290-1ML - PSMB8 Antibody
OACD05290-1ML 1ml
EUR 639

OAAN02231-50UL - PSMB8 Antibody
OAAN02231-50UL 50ul
EUR 149

PSMB8 Antibody, Biotin conjugated
1-CSB-PA018886LD01HU
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

PSMB8 Antibody, Biotin Conjugated
MBS7113269-005mL 0.05mL
EUR 190

PSMB8 Antibody, Biotin Conjugated
MBS7113269-01mL 0.1mL
EUR 270

PSMB8 Antibody, Biotin Conjugated
MBS7113269-5x01mL 5x0.1mL
EUR 1205

OACD05288-100UL - PSMB8 Antibody
OACD05288-100UL 100ul
EUR 199

OACD05289-100UL - PSMB8 Antibody
OACD05289-100UL 100ul
EUR 189

OACD05290-100UL - PSMB8 Antibody
OACD05290-100UL 100ul
EUR 189

OAGA01026-100UL - PSMB8 antibody
OAGA01026-100UL 100ul
EUR 369